A Phase Ia.Ib, Open Label, Multicenter, Dose-escalation Study of BI 907828 in Patients With Advance or Metastatic Solid Tumors

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Abhijeet Kumar
Sponsor
Boehringer Ingelheim Pharmaceuticals, Inc
Unit
Cancer Center Division